Mankind Pharma Limited (MANKIND) — regulation 31 | 10 June 2026

StockFin.ai

Try Free

📢 Key Event
Promoters confirmed no encumbrance on shares held during FY2026.

💡 Investor Takeaway
Shareholders can view this as a compliance confirmation with no impact on current holdings.

Mankind Pharma Limited disclosed on April 7, 2026, that its promoters and promoter group, including persons acting in concert, confirmed no encumbrance on shares held during the financial year ended March 31, 2026, as required under SEBI Regulation 31(4).

📄 View Original Announcement (PDF)

📊 Stock Analysis — MANKIND ✨ Ask AI About This

About Mankind Pharma Limited (MANKIND)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,03,330.93 Cr P/E: 49.2

View full MANKIND stock details →

📡 Get AI alerts when MANKIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MANKIND — Free

💡 Ask AI about this filing

"How does this affect MANKIND margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More MANKIND filings

See all MANKIND filings →

🔥 Also filed on 10 June 2026

WHIRLPOOL Whirlpool of India Limited Announcement LTM LTM Limited Announcement RANEHOLDIN Rane Holdings Limited Announcement BHARATRAS Bharat Rasayan Limited Announcement RADIANTCMS Radiant Cash Management Services Limited Insider Trading GICHSGFIN GIC Housing Finance Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when MANKIND files new disclosures

Track MANKIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MANKIND — Free

Free account · 2 AI queries/day